222 related articles for article (PubMed ID: 11835348)
21. Manifestations of three HHV-8-related diseases in an HIV-negative patient: immunoblastic variant multicentric Castleman's disease, primary effusion lymphoma, and Kaposi's sarcoma.
Codish S; Abu-Shakra M; Ariad S; Zirkin HJ; Yermiyahu T; Dupin N; Boshoff C; Sukenik S
Am J Hematol; 2000 Dec; 65(4):310-4. PubMed ID: 11074561
[TBL] [Abstract][Full Text] [Related]
22. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.
Jaffe ES; Zarate-Osorno A; Medeiros LJ
Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852
[TBL] [Abstract][Full Text] [Related]
23. [Large B-cell lymphoma coexisting with Castleman's disease. Report of one case].
Avilés-Salas A; Candelaria M; Sevilla-Lizcano DB; Burgos S
Rev Med Chil; 2017 Jul; 145(7):945-949. PubMed ID: 29182205
[TBL] [Abstract][Full Text] [Related]
24. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period.
Ho FC; Todd D; Loke SL; Ng RP; Khoo RK
Int J Cancer; 1984 Aug; 34(2):143-8. PubMed ID: 6381328
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies.
Menke DM; Tiemann M; Camoriano JK; Chang SF; Madan A; Chow M; Habermann TM; Parwaresch R
Am J Clin Pathol; 1996 Mar; 105(3):268-76. PubMed ID: 8602606
[TBL] [Abstract][Full Text] [Related]
26. Mantle cell lymphoma superimposed on multicentric Castleman's disease.
Yoshida T; Sakai A; Imagawa J; Noda M; Takada S; Yoshino T; Kimura A
J Clin Exp Hematop; 2011; 51(2):147-50. PubMed ID: 22104315
[No Abstract] [Full Text] [Related]
27. IL-6-positive classical Hodgkin's lymphoma co-occurring with plasma cell type of Castleman's disease: report of a case.
Momoi A; Kojima M; Sakai T; Ajiro J; Isahai N; Nagai K; Aoki S
Int J Hematol; 2013 Feb; 97(2):275-9. PubMed ID: 23359301
[TBL] [Abstract][Full Text] [Related]
28. Discordant lymphocyte-depleted classical Hodgkin's and peripheral T-cell lymphoma arising in a patient 11 years after diagnosis of multicentric Castleman's disease.
Park J; Lee JE; Kim M; Lim J; Kim Y; Han K; Park G; Jung YH; Roh SY; Hong YS
Int J Hematol; 2013 Jul; 98(1):114-21. PubMed ID: 23733446
[TBL] [Abstract][Full Text] [Related]
29. [Association of Castleman's disease and Hodgkin's disease. Eight cases and review of the literature].
Molinié V; Périé G; Mélo I; Melo C; Audouin J; Diebold J
Ann Pathol; 1994; 14(6):384-91. PubMed ID: 7857413
[TBL] [Abstract][Full Text] [Related]
30. Non-Hodgkin's lymphoma of the brain after Hodgkin's disease. An immunohistochemical study.
Davenport RD; O'Donnell LR; Schnitzer B; McKeever PE
Cancer; 1991 Jan; 67(2):440-3. PubMed ID: 1985737
[TBL] [Abstract][Full Text] [Related]
31. Hodgkin's disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors.
Andrieu JM; Roithmann S; Tourani JM; Levy R; Desablens B; le Maignan C; Gastaut JA; Brice P; Raphael M; Taillan B
Ann Oncol; 1993 Sep; 4(8):635-41. PubMed ID: 8240994
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Castleman's disease.
Dispenzieri A; Gertz MA
Curr Treat Options Oncol; 2005 May; 6(3):255-66. PubMed ID: 15869736
[TBL] [Abstract][Full Text] [Related]
33. A possible new morphological variant of mantle cell lymphoma with plasma-cell type Castleman disease-like features.
Igawa T; Omote R; Sato H; Taniguchi K; Miyatani K; Yoshino T; Sato Y
Pathol Res Pract; 2017 Nov; 213(11):1378-1383. PubMed ID: 28974340
[TBL] [Abstract][Full Text] [Related]
34. [Incomplete POEMS syndrome with multicentric Castleman's disease].
González de la Aleja P; García-Navarro M; Sánchez-Martínez R; Ramos JM
An Sist Sanit Navar; 2017 Dec; 40(3):475-478. PubMed ID: 28906499
[TBL] [Abstract][Full Text] [Related]
35. Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma.
Re A; Casari S; Cattaneo C; Facchetti F; Cadeo G; Carosi G; Rossi G
Cancer; 2001 Dec; 92(11):2739-45. PubMed ID: 11753946
[TBL] [Abstract][Full Text] [Related]
36. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of clonality in Castleman's disease.
Soulier J; Grollet L; Oksenhendler E; Micléa JM; Cacoub P; Baruchel A; Brice P; Clauvel JP; d'Agay MF; Raphael M
Blood; 1995 Aug; 86(3):1131-8. PubMed ID: 7620166
[TBL] [Abstract][Full Text] [Related]
38. Hodgkin's disease after treatment of non-Hodgkin's lymphoma.
Carrato A; Filippa D; Koziner B
Cancer; 1987 Aug; 60(4):887-96. PubMed ID: 3594408
[TBL] [Abstract][Full Text] [Related]
39. Hodgkin's and Castleman's disease in a patient with systemic mastocytosis.
Saletti P; Ghielmini M; Scali G; Pedrinis E; Guéneau M; Cavalli F
Ann Hematol; 1999 Feb; 78(2):97-100. PubMed ID: 10089028
[TBL] [Abstract][Full Text] [Related]
40. Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease).
Abdel-Reheim FA; Koss W; Rappaport ES; Arber DA
Arch Pathol Lab Med; 1996 Jan; 120(1):91-6. PubMed ID: 8554455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
